Cargando…
In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin
OBJECTIVES: This study aimed to investigate in-hospital mortality rates in patients with coronavirus disease (COVID-19) according to enoxaparin and heparin use. METHODS: This retrospective cohort study included 962 patients admitted to two hospitals in Kuwait with a confirmed diagnosis of COVID-19....
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608030/ https://www.ncbi.nlm.nih.gov/pubmed/36285386 http://dx.doi.org/10.1177/10760296221131802 |
_version_ | 1784818684413345792 |
---|---|
author | Alroomi, Moudhi Alsaber, Ahmad Al-Bader, Bader Almutairi, Farah Malhas, Haya Pan, Jiazhu Zhanna, Kobalava D. Ramadhan, Maryam Saleh, Mohammad Al Abdullah, Mohammed Alotaibi, Naser AlNasrallah, Noor Rajan, Rajesh Hussein, Soumoud Aboelhassan, Wael |
author_facet | Alroomi, Moudhi Alsaber, Ahmad Al-Bader, Bader Almutairi, Farah Malhas, Haya Pan, Jiazhu Zhanna, Kobalava D. Ramadhan, Maryam Saleh, Mohammad Al Abdullah, Mohammed Alotaibi, Naser AlNasrallah, Noor Rajan, Rajesh Hussein, Soumoud Aboelhassan, Wael |
author_sort | Alroomi, Moudhi |
collection | PubMed |
description | OBJECTIVES: This study aimed to investigate in-hospital mortality rates in patients with coronavirus disease (COVID-19) according to enoxaparin and heparin use. METHODS: This retrospective cohort study included 962 patients admitted to two hospitals in Kuwait with a confirmed diagnosis of COVID-19. Cumulative all-cause mortality rate was the primary outcome. RESULTS: A total of 302 patients (males, 196 [64.9%]; mean age, 57.2 ± 14.6 years; mean body mass index, 29.8 ± 6.5 kg/m(2)) received anticoagulation therapy. Patients receiving anticoagulation treatment tended to have pneumonia (n = 275 [91.1%]) or acute respiratory distress syndrome (n = 106 [35.1%]), and high D-dimer levels (median [interquartile range]: 608 [523;707] ng/mL). The mortality rate in this group was high (n = 63 [20.9%]). Multivariable logistic regression, the Cox proportional hazards, and Kaplan-Meier models revealed that the use of therapeutic anticoagulation agents affected the risk of all-cause cumulative mortality. CONCLUSION: Age, hypertension, pneumonia, therapeutic anticoagulation, and methylprednisolone use were found to be strong predictors of in-hospital mortality. In elderly hypertensive COVID-19 patients on therapeutic anticoagulation were found to have 2.3 times higher risk of in-hospital mortality. All cause in-hospital mortality rate in the therapeutic anticoagulation group was up to 21%. |
format | Online Article Text |
id | pubmed-9608030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-96080302022-10-28 In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin Alroomi, Moudhi Alsaber, Ahmad Al-Bader, Bader Almutairi, Farah Malhas, Haya Pan, Jiazhu Zhanna, Kobalava D. Ramadhan, Maryam Saleh, Mohammad Al Abdullah, Mohammed Alotaibi, Naser AlNasrallah, Noor Rajan, Rajesh Hussein, Soumoud Aboelhassan, Wael Clin Appl Thromb Hemost Original Manuscript OBJECTIVES: This study aimed to investigate in-hospital mortality rates in patients with coronavirus disease (COVID-19) according to enoxaparin and heparin use. METHODS: This retrospective cohort study included 962 patients admitted to two hospitals in Kuwait with a confirmed diagnosis of COVID-19. Cumulative all-cause mortality rate was the primary outcome. RESULTS: A total of 302 patients (males, 196 [64.9%]; mean age, 57.2 ± 14.6 years; mean body mass index, 29.8 ± 6.5 kg/m(2)) received anticoagulation therapy. Patients receiving anticoagulation treatment tended to have pneumonia (n = 275 [91.1%]) or acute respiratory distress syndrome (n = 106 [35.1%]), and high D-dimer levels (median [interquartile range]: 608 [523;707] ng/mL). The mortality rate in this group was high (n = 63 [20.9%]). Multivariable logistic regression, the Cox proportional hazards, and Kaplan-Meier models revealed that the use of therapeutic anticoagulation agents affected the risk of all-cause cumulative mortality. CONCLUSION: Age, hypertension, pneumonia, therapeutic anticoagulation, and methylprednisolone use were found to be strong predictors of in-hospital mortality. In elderly hypertensive COVID-19 patients on therapeutic anticoagulation were found to have 2.3 times higher risk of in-hospital mortality. All cause in-hospital mortality rate in the therapeutic anticoagulation group was up to 21%. SAGE Publications 2022-10-25 /pmc/articles/PMC9608030/ /pubmed/36285386 http://dx.doi.org/10.1177/10760296221131802 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Manuscript Alroomi, Moudhi Alsaber, Ahmad Al-Bader, Bader Almutairi, Farah Malhas, Haya Pan, Jiazhu Zhanna, Kobalava D. Ramadhan, Maryam Saleh, Mohammad Al Abdullah, Mohammed Alotaibi, Naser AlNasrallah, Noor Rajan, Rajesh Hussein, Soumoud Aboelhassan, Wael In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title | In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title_full | In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title_fullStr | In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title_full_unstemmed | In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title_short | In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin |
title_sort | in-hospital mortality rates in sars-cov-2 patients treated with enoxaparin and heparin |
topic | Original Manuscript |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608030/ https://www.ncbi.nlm.nih.gov/pubmed/36285386 http://dx.doi.org/10.1177/10760296221131802 |
work_keys_str_mv | AT alroomimoudhi inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT alsaberahmad inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT albaderbader inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT almutairifarah inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT malhashaya inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT panjiazhu inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT zhannakobalavad inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT ramadhanmaryam inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT salehmohammadal inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT abdullahmohammed inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT alotaibinaser inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT alnasrallahnoor inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT rajanrajesh inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT husseinsoumoud inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin AT aboelhassanwael inhospitalmortalityratesinsarscov2patientstreatedwithenoxaparinandheparin |